Benzinga's Top Downgrades

Analysts at Morgan Stanley downgraded Gilead Sciences, Inc. GILD from Overweight to Equal-weight. The price target for Gilead Sciences is set to $127. Gilead Sciences shares closed at $98.27 on Thursday. UBS downgraded T. Rowe Price Group Inc TROW from Buy to Neutral. The price target for T. Rowe Price Group has been lowered from $86 to $68. T. Rowe Price Group shares closed at $68.59 on Thursday. Analysts at Morgan Stanley downgraded Diplomat Pharmacy Inc DPLO from Overweight to Equal-weight. The price target for Diplomat Pharmacy has been lowered from $58 to $31. Diplomat Pharmacy shares closed at $29.50 on Thursday. UBS downgraded LPL Financial Holdings Inc LPLA from Neutral to Sell. LPL Financial shares closed at $39.39 on Thursday. BB&T Capital downgraded Orion Marine Group, Inc. ORN from Buy to Hold. Orion Marine Group shares closed at $5.96 on Thursday. Analysts at Morgan Stanley downgraded Valeant Pharmaceuticals Intl Inc VRX from Overweight to Equal-weight. The price target for Valeant Pharmaceuticals has been lowered from $284 to $200. Valeant Pharmaceuticals shares closed at $179.60 on Thursday. Analysts at Goldman Sachs downgraded Fifth Third Bancorp FITB from Buy to Neutral. The price target for Fifth Third Bancorp has been lowered from $22.50 to $21. Fifth Third Bancorp shares closed at $18.97 on Thursday. Analysts at Stifel Nicolaus downgraded QTS Realty Trust Inc QTS from Buy to Hold. QTS Realty shares closed at $44.34 on Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!